Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT03307486

Gestational Diabetes: a Cohort Study

Fetal and Maternal Repercussions of Gestational Diabetes After the Adoption of the Diagnostic Criteria Proposed by the International Association of Diabetes and Pregnancy Study Groups (IADPSG): a Cohort Study

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
1,400 (estimated)
Sponsor
University of Sao Paulo General Hospital · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

Gestational diabetes (GDM) is the most common hormonal complication during pregnancy. Its occurrence implies an increased risk of maternal and fetal complications and, therefore, its diagnosis and treatment are extremely important. Since the adoption of the new diagnostic criteria proposed by the International Association of Diabetes and Pregnancy Study Groups (IADPSG) in 2010, an increasing number of cases of mild hyperglycemia have demanded follow-up and treatment. The need and benefit of treatment in these cases of mild hyperglycemia has been discussed worldwide. Women who have been diagnosed with GDM are at increased risk for type 2 DM in the years following gestation. Other factors (such as lipid profile, obesity, adipokine dosage) may also be related to the repercussions of GDM on the maternal-fetal binomial, since gestations with satisfactory glycemic control can also present complications related to the disease and increased risk of type 2 DM in the long term. The present study aims to investigate factors associated with the need for insulin use, the occurrence of perinatal complications, nutritional status, physical activity and weight retention one year after delivery and the postpartum diagnosis of type 2 DM 10 years after delivery in women diagnosed with GDM according to the current criteria suggested by the IADPSG.

Conditions

Timeline

Start date
2015-09-17
Primary completion
2030-06-01
Completion
2030-12-01
First posted
2017-10-11
Last updated
2017-10-12

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT03307486. Inclusion in this directory is not an endorsement.